BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Benson BC, Shaw PJ, Azzouz M, Highley JR, Hautbergue GM. Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis. Front Neurosci 2021;15:783624. [PMID: 35002606 DOI: 10.3389/fnins.2021.783624] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Günther R. [Gene Therapies in Motor Neuron Diseases ALS and SMA]. Fortschr Neurol Psychiatr 2023. [PMID: 36822211 DOI: 10.1055/a-2002-5215] [Reference Citation Analysis]
2 Giovannelli I, Higginbottom A, Kirby J, Azzouz M, Shaw PJ. Prospects for gene replacement therapies in amyotrophic lateral sclerosis. Nat Rev Neurol 2023;19:39-52. [PMID: 36481799 DOI: 10.1038/s41582-022-00751-5] [Reference Citation Analysis]
3 Phan K, He Y, Bhatia S, Pickford R, McDonald G, Mazumder S, Timmins HC, Hodges JR, Piguet O, Dzamko N, Halliday GM, Kiernan MC, Kim WS. Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis. Brain Commun 2023;5:fcac340. [PMID: 36632187 DOI: 10.1093/braincomms/fcac340] [Reference Citation Analysis]
4 Braun MM, Puglielli L. Defective PTEN-induced kinase 1/Parkin mediated mitophagy and neurodegenerative diseases. Front Cell Neurosci 2022;16:1031153. [DOI: 10.3389/fncel.2022.1031153] [Reference Citation Analysis]
5 Proaño B, Casani-cubel J, Benlloch M, Rodriguez-mateos A, Navarro-illana E, Lajara-romance JM, de la Rubia Ortí JE. Is Dutasteride a Therapeutic Alternative for Amyotrophic Lateral Sclerosis? Biomedicines 2022;10:2084. [DOI: 10.3390/biomedicines10092084] [Reference Citation Analysis]
6 Shibuya K, Otani R, Suzuki Y, Kuwabara S, Kiernan MC. Neuronal Hyperexcitability and Free Radical Toxicity in Amyotrophic Lateral Sclerosis: Established and Future Targets. Pharmaceuticals 2022;15:433. [DOI: 10.3390/ph15040433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Candelise N, Salvatori I, Scaricamazza S, Nesci V, Zenuni H, Ferri A, Valle C. Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship. Metabolites 2022;12:233. [DOI: 10.3390/metabo12030233] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
8 Pansarasa O, Garofalo M, Scarian E, Dragoni F, Garau J, Di Gerlando R, Diamanti L, Bordoni M, Gagliardi S. Biomarkers in Human Peripheral Blood Mononuclear Cells: The State of the Art in Amyotrophic Lateral Sclerosis. Int J Mol Sci 2022;23:2580. [PMID: 35269723 DOI: 10.3390/ijms23052580] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Gunes ZI, Kan VWY, Jiang S, Logunov E, Ye X, Liebscher S. Cortical Hyperexcitability in the Driver’s Seat in ALS. CTN 2022;6:5. [DOI: 10.3390/ctn6010005] [Reference Citation Analysis]